ALLYX THERAPEUTICS
Live / Applied — Fourth extension granted (statement of use) (as of 15 May 2025)
What this means for you
Not registered yet, but its 24 Feb 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97282621
- Mark type
- Stylized text
- Filed
- 24 Feb 2022
- Published for opposition
- 17 Jan 2023
- Attorney of record
- Glenn M. Cunningham
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for use in the prevention and treatment of neurodegenerative diseases, but not including products for the treatment of hemophilia
Owner
- Allyx Therapeutics, Inc., New Haven, CT, US
- Allyx Therapeutics, Inc., New Haven, CT, US
Prosecution history
- 07 Jan 2026 — SOU TEAS EXTENSION RECEIVED
- 16 May 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 16 May 2025 — SOU EXTENSION 4 GRANTED
- 15 May 2025 — SOU EXTENSION 4 FILED
- 15 May 2025 — SOU TEAS EXTENSION RECEIVED
- 04 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 09 Jan 2025 — SOU EXTENSION 3 GRANTED
- 09 Jan 2025 — SOU EXTENSION 3 FILED
- 09 Jan 2025 — SOU TEAS EXTENSION RECEIVED
- 31 Oct 2024 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 31 Oct 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 31 Oct 2024 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 31 Oct 2024 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 31 Oct 2024 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 31 Oct 2024 — TEAS CHANGE OF OWNER ADDRESS RECEIVED